Valeant taps CEO Pearson as chairman; Asthma drug helps kids with milk allergies;

@FiercePharma: J&J chief hopes missing drugs return by year's end. News | Follow @FiercePharma

> Valeant Pharmaceuticals has appointed CEO Michael Pearson as chairman of the board and extended his contract until February 2017. Report

> Novartis and Roche's Xolair, a medication used to treat asthma attacks caused by allergens such as pollen and dust mites, helped children overcome milk allergies, a small study showed. News

> Pozen filed a motion to prevent generic drugmaker Par Pharmaceutical from launching a copycat version of its migraine drug Treximet. Story

> GW Pharmaceuticals' pioneering cannabis drug Sativex has been recommended for approval in the six other European countries targeted by the British company and Spanish partner Almirall. Item

> Lonza has been awarded two contracts for biological drug candidates in quick succession, including a new deal that will make use of its large-scale U.S. biopharmaceutical facility in New Hampshire. Article

> A subsidiary of Watson Pharmaceuticals has launched a treatment for herpes infections. Story

Biotech News

@FierceBiotech: GSK's Witty: Development must be radically restructured in R&D revolution. Report | Follow @FierceBiotech

@JohnCFierce: Lilly's Lechleiter insists there will be no mega mergers for the 543rd time. Beijing report oddly misspells his name. Article | Follow @JohnCFierce

> Cephalon scoops up cancer drugs in $525M Gemin X buyout. News 

> Bristol's breakthrough melanoma drug delivers promising data in Ph3. Item 

> Peptimmune heads into bankruptcy after venture round fizzles. Article 

Biotech Research News

> Shar-pei DNA reveals new wrinkle in fever disorders. Article

> TB protein discovery could lead to better vax. News

> UK, UMass stem cell banks join forces. Story 

> Bluebird bio's gene therapy hits a high note. Report 

 Manufacturing News

> Little buzz for Obama's track/trace proposal. Item 

> Industry lobbies for foreign plant inspections. Article

> USP, FDA update quality standards for common drugs. Report 

> Genzyme: Fill/finish causes Thyrogen shortage. News

> Consent decree diminishes CEO Weldon's role in McNeil turnaround. Article 

> FDA, EMA team on QbD-based joint reviews. Story

And Finally... A new test for human papillomavirus is just as sensitive as the old one, but more specific for detecting cervical cancer, meaning that it has fewer false positive results. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.